Form 4: Tesla Director Sells Shares After Option Exercise
Insider Transaction Report
Tesla Director Kathleen Wilson-Thompson exercised stock options and subsequently sold a portion of her common stock holdings under a pre-arranged 10b5-1 trading plan.
Summary
- Kathleen Wilson-Thompson, a Director of Tesla, Inc., acquired 40,000 shares of common stock by exercising non-qualified stock options at a price of $14.99 per share on March 30, 2026.
- On the same date, she sold a total of 38,547 shares of Tesla common stock in multiple transactions.
- The sales occurred at weighted average prices ranging from $352.833 to $366.855 per share.
- All reported transactions were executed under a Rule 10b5-1 trading plan established on November 26, 2025.
- Following these transactions, Ms. Wilson-Thompson directly owns 33,860 shares of common stock and 40,948 derivative securities (non-qualified stock options).
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. The transactions are routine insider activity under a 10b5-1 plan, reflecting personal financial management rather than a statement on company performance. The profitable exercise of options is a positive for the individual director.
Positives
- Transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned diversification strategy rather than a reaction to new, non-public information.
- The exercise of options at a low strike price ($14.99) and subsequent sale at significantly higher market prices ($352.833 $366.855) demonstrates a profitable realization of compensation.
Negatives
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence, though this is mitigated by the pre-planned nature.
- A reduction in direct common stock holdings by a director, from 59,669 shares to 33,860 shares after the option exercise and sales, represents a decrease in direct equity exposure.
Future Outlook
The filing does not provide specific forward-looking statements or guidance beyond the execution of a pre-established trading plan.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are common among executives and directors for personal financial planning, diversification, and liquidity purposes. While the sale of shares by a director might typically draw scrutiny, the pre-arranged nature of the 10b5-1 plan suggests these transactions are routine and not indicative of new, material non-public information regarding Tesla's operational performance or future prospects. This is a standard practice across the technology and automotive sectors for highly compensated individuals.
Stakeholder Impact
- Shareholders: The sale of shares by a director could be perceived negatively by some shareholders, but the 10b5-1 plan mitigates concerns about opportunistic selling. The overall impact on the company's stock price from this single transaction is likely minimal.
- Employees: No direct impact on employees.
- Customers: No direct impact on customers.
- Suppliers: No direct impact on suppliers.
- Creditors: No direct impact on creditors.
Key Dates
| Date | Description |
|---|---|
| 2019-06-18 | Start date for monthly vesting of non-qualified stock options. |
| 2022-06-18 | Date by which all shares subject to the non-qualified stock option were fully vested and exercisable. |
| 2025-11-26 | Date Rule 10b5-1 trading plan was adopted by Kathleen Wilson-Thompson. |
| 2026-03-30 | Date of stock option exercise and subsequent common stock sales. |
| 2026-06-18 | Expiration date of the non-qualified stock option. |
Recommendation
holdThis Form 4 filing details routine insider transactions (option exercise and subsequent share sales) executed under a pre-arranged 10b5-1 plan. Such transactions are typically for personal financial planning and diversification and do not inherently signal a change in the company's fundamental outlook or warrant a change in investment recommendation. The profitable exercise of options is a positive for the director, but the overall impact on Tesla's investment thesis is neutral. Therefore, a 'hold' recommendation remains appropriate based solely on this filing, pending further operational or strategic updates.
Keywords
Tesla, TSLA, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Kathleen Wilson-Thompson, 10b5-1 Plan, Director Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.